Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Somerville, Massachusetts
- Most recent report
- 8-K, filed Aug 26, 2026
- Incorporated
- Delaware
- Filings on record
- 53 filings
- On EDGAR
- CIK 2100782
- Fiscal year ends
- December
- Filer status
- Emerging growth company
Financials 2
News 4
Prospectuses and Registrations 5
Ownership 8 of 38
- 4 Insider reported a trade Sep 3, 2026
- 144 Notice of a proposed sale of restricted stock Sep 2, 2026
- 144 Notice of a proposed sale of restricted stock Sep 1, 2026
- SCHEDULE 13G Large holder reported a passive stake May 15, 2026
- SCHEDULE 13G Large holder reported a passive stake May 15, 2026
- 3 Insider reported their initial holding Mar 12, 2026
- 4 Insider reported a trade Mar 6, 2026
- 4 Insider reported a trade Mar 2, 2026
Other 4
Everything here comes from Generate Biomedicines, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.